Vertical transmission of the hepatitis C virus: Current knowledge and issues

Paediatrics and Child Health

Volumn 13, Issue 6, 2008, Pages

  Bortolussi, Robert ^a   Finlay, Jane ^b   Moore, Dorothy L ^c   Robinson, Joan Louise ^b,h   Rousseau Harsany, Élisabeth ^d   Samson, Lindy Michelle ^e   MacDonald, Noni E ^a   Allen, Upton Dilworth ^f   Hui, Charles P S ^e   Saux, Nicole Le ^e   Pickering, Larry ^b   Salvadori, Marina Ines ^g  

^a IWK HEALTH CENTRE   (Canada)

^b The Montreal Children's Hospital ^*

^c MONTREAL CHILDREN S HOSPITAL   (Canada)

^d UNIVERSITY OF MONTREAL   (Canada)

^e CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^f HOSPITAL FOR SICK CHILDREN   (Canada)

^g CHILDREN S HOSPITAL OF WESTERN ONTARIO   (Canada)

^h UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; RIBAVIRIN; VIRUS RNA;

ARTICLE; BREAST FEEDING; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; PATIENT COUNSELING; PREGNANT WOMAN; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SCREENING TEST; SEROPREVALENCE; VERTICAL TRANSMISSION; VIRAL CONTAMINATION; VIRUS TRANSMISSION;

EID: 57549118905     PISSN: 12057088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998;47:1-39.
2. Canadian Paediatric Society, Infectious Diseases and Immunization Committee [Principal author: G Delage]. Vertical transmission of the hepatitis C virus: Current knowledge and issues. Paediatr Child Health 1997;2:227-31.
3. Zahariadis G, Plitt SS, O'Brien S, Yi QL, Fan W, Preiksaitis JK. Prevalence and estimated incidence of blood-borne viral pathogen infection in organ and tissue donors from northern Alberta. Am J Transplant 2007;7:226-34.
4. Xeroulis G, Inaba K, Stewart TC, et al. Human immunodeficiency virus, hepatitis B, and hepatitis C seroprevalence in a Canadian trauma population. J Trauma 2005;59:105-8.
5. Minuk GY, Uhanova J. Viral hepatitis in the Canadian Inuit and First Nations populations. Can J Gastroenterol 2003;17:707-12.
6. O'Brien SF, Yi QL, Fan W, Scalia V, Kleinman SH, Vamvakas EC. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services. Transfusion 2007;47:316-25.
7. Blanchette V, Walker I, Gill P, Adams M, Roberts R, Inwood M. Hepatitis C infection in patients with hemophilia: Results of a national survey. Canadian Hemophilia Clinic Directors Group. Transfus Med Rev 1994;8:210-7.
8. Fingerhood MI, Jasinski DR, Sullivan JT. Prevalence of hepatitis C in a chemically dependent population. Arch Intern Med 1993; 153:2025-30.
9. Chaudhary RK, Mo T. Antibody to hepatitis C virus in risk groups in Canada. Can Dis Wkly Rep 1990;16:23-5.
10. Prevention and control of hepatitis C. Guidelines and recommendations. Can Commun Dis Rep 1995;21 (Suppl 2):1 -1B.
11. Alter MJ, Hadler SC, Judson FN, et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990;264:2231-5.
12. Roy E, Alary M, Morissette C, et al; SurvUDI Working Group. High hepatitis C virus prevalence and incidence among Canadian intravenous drug users. Int J STD AIDS 2007; 18:23-7.
13. Airoldi J, Berghella V. Hepatitis C and pregnancy. Obstet Gynecol Surv 2006;61:666-72.
14. European Paediatric Hepatitis C Virus Network. Three broad modalities in the natural history of vertically acquired hepatitis C virus infection. Clin Infect Dis 2005;41:45-51.
15. Radkowki M, Horban A, Gallegos-Orozco JF, et al. Evidence for viral persistence in patients who test positive for anti-hepatitis C virus antibodies and have normal alanine aminotransferase levels. J Infect Dis 2005;191:1730-3.
16. Carreño V. Occult hepatitis C virus infection: A new form of hepatitis C. World J Gastroenterol 2006;12:6922-5.
17. Iorio R, Giannattasio A, Sepe A, Terracciano LM, Vecchione R, Vegnente A. Chronic hepatitis C in childhood: An 18-year experience. Clin Infect Dis 2005;41:1431-7.
18. Yeung LT, To T, King SM, Roberts EA. Spontaneous clearance of childhood hepatitis C virus infection. J Viral Hepat 2007;14:797-805.
19. Castillo I, Pardo M, Bartolomé J, et al. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J Infect Dis 2004;189:7-14.
20. Mohan P, Colvin C, Glymph C, et al. Clinical spectrum and histopathologic features of chronic hepatitis C infection in children. J Pediatr 2007;150:168-74,174.e1.
21. Badizadegan K, Jonas MM, Ott MJ, Nelson SP, Perez-Atayde AR. Histopathology of the liver in children with chronic hepatitis C viral infection. Hepatology 1998;28:1416-23.
22. Kumar RM, Frossad PM, Hughes PF. Seroprevalence and mother-to-infant transmission of hepatitis C in asymptomatic Egyptian women. Eur J Obstet Gynecol Reprod Biol 1997;75:177-82.
23. Yeung LT, King SM, Roberts EA. Mother-to-infant transmissionof hepatitis C virus. Hepatology 2001;34:223-9.
24. European Paediatric Hepatitis C Virus Network. A significant sex - but not elective cesarean section - effect on mother-to-child transmission of hepatitis C virus infection. J Infect Dis 2005;192:1872-9.
25. Indolfi G, Azzari C, Moriondo M, Lippi F, de Martino M, Resti M. Alanine transaminase levels in the year before pregnancy predict the risk of hepatitis C virus vertical transmission. J Med Virol 2006;78:911-4.
26. Kuroki T, Nishiguchi S, Fukuda K, et al. Transmission of hepatitis C virus from mothers with chronic hepatitis C without human immunodeficiency virus. J Infect Dis 1992;166:1192-3.
27. Novati R, Thiers V, Monforte AD, et al. Mother-to-child transmission of hepatitis C virus detected by nested polymerase chain reaction. J Infect Dis 1992;165:720-3.
28. Ohto H, Terazawa S, Sasaki N, et al. Transmission of hepatitis C virus from mothers to infants. The Vertical Transmission of Hepatitis C Virus Collaborative Study Group. N Engl J Med 1994;330:744-50.
29. Zanetti AR, Tanzi E, Paccagnini S, et al. Mother-to-infant transmission of hepatitis C virus. Lombardy Study Group on Vertical HCV Transmission. Lancet 1995;345:289-91.
30. Weiner AJ, Thaler MM, Crawford K, et al. HCV-positive, HIV-negative mothers transmit HCV. In: Nishioka K, Suzuki H, Mishiro S, Oda T, eds. Viral Hepatitis and Liver Disease. Tokyo: Springer-Verlag, 1994:474-7.
31. Barlow KM, Mok JY. Dizygotic twins discordant for HIV and hepatitis C virus. Arch Dis Child 1993;68:507.
32. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1 - a meta-analysis of 15 prospective cohort studies. The International Perinatal HIV Group. N Engl J Med 1999;340:977-87.
33. Mast EE, Hwang LY, Seto DS, et al. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis 2005;192:1880-9.
34. England K, Pembrey L, Tovo PA, Newell ML; European Paediatric HCV Network. Excluding hepatitis C virus (HCV) infection by serology in young infants of HCV-infected mothers. Acta Paediatr 2005; 94:444-50. (Erratum in 2005;94:814).
35. Sagnelli E, Coppola N, Pisaturo M, et al. Clinical and virological improvement of hepatitis B virus-related or hepatitics C virus-related chronic hepatitis with concomitant hepatitis A virus infection. Clin Infect Dis 2006;42:1536-43. (Erratum in 2006;43:121).
36. American Academy of Pediatrics, Committee on Sports Medicine and Fitness. Human immunodeficiency virus and other blood-borne viral pathogens in the athletic setting. Pediatrics 1999;104:1400-3.